PHSRX Mutual Fund

PHSRX Mutual Fund

NAV$56.90
See how much of PHSRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 46 of 46 holdings · as of Jul 31, 2026
PHSRX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
13.19%
13.2%173,300$199.09MHealth CarePharmaceuticals
2
JNJ
Johnson & Johnson -Health Care · Pharmaceuticals
9.29%
22.5%547,243$140.29MHealth CarePharmaceuticals
Sector and industry · Pro
3
UNH
Unitedhealth Group Inc
7.29%
29.8%265,560$110.05M
4
ABBV
AbbVie Inc.
6.73%
36.5%404,800$101.58M
5
MRK
Merck & Company Inc
5.64%
42.1%653,871$85.13M
6
NVS
Novartis Ag Ordinary Shares
5.15%
47.3%497,166$77.75M
7—AstraZeneca PLC
4.13%
51.4%366,624$62.37M
8
TMO
Thermo Fisherscientific Inc.
3.85%
55.3%101,160$58.10M
9
ISRG
Intuitive Surgical Inc.
3.24%
58.5%138,620$48.98M
10
CVS
Cvs Health Corp.
3.03%
61.5%438,000$45.74M
11
GILD
Gilead Sciences
3.00%
64.5%347,600$45.26M
12
RO
Roche Holding Ag
2.80%
67.3%96,648$42.24M
13
EW
Edwards Lifesciences Corp
2.69%
70.0%472,300$40.65M
14—Vertex Pharmaceuticals Inc
2.52%
72.5%79,860$38.10M
15
CAH
Cardinal Health Inc.
2.39%
74.9%156,600$36.02M
16
MCK
Mckesson Corp.
2.38%
77.3%42,040$35.99M
17—Gsk Plc Common Stock Gbp
2.27%
79.6%1,320,887$34.35M
18
ELV
Elevance Health Inc
1.94%
81.5%77,760$29.23M
19
DXCM
Dexcom Inc.
1.79%
83.3%323,300$26.98M
20
WAT
Waters Corp.
1.46%
84.8%58,320$22.00M
21
NVO
Novo Nordisk Class B
1.37%
86.1%435,843$20.62M
22—Hoya Corp
1.32%
87.5%130,100$19.89M
23
AMGN
Amgen Inc.
1.22%
88.7%47,920$18.46M
24
SNY
Sanofi SA
1.17%
89.9%204,385$17.60M
25
BMY
Bristol-Myers Squibb Co.
1.09%
90.9%251,900$16.45M
26—Argenx
0.91%
91.9%16,105$13.79M
27—Royalty Pharma PLC - Class A Shares
0.86%
92.7%221,800$12.96M
28—Chugai Pharmaceutical Co., Ltd.
0.70%
93.4%244,800$10.62M
29
INSM
Insmed Inc Sedol 2614487
0.69%
94.1%106,400$10.49M
30
PACS
Pacs Group Inc
0.63%
94.7%205,800$9.47M
31
PTGX
Protagonist Therapeutics Inc
0.59%
95.3%65,400$8.94M
32
XENE
Xenon Pharmaceuticals Inc. Common Shares
0.55%
95.9%133,500$8.37M
33
UTHR
United Therapeutics Corp
0.54%
96.4%15,840$8.20M
34
LGND
Ligand Pharmaceuticals, Inc.
0.53%
96.9%27,700$7.96M
35
RYTM
Rhythm Pharmaceuticals Inc
0.51%
97.5%76,900$7.63M
36
ASND
Ascendis Pharma A/S
0.51%
98.0%31,288$7.63M
37
CELC
Celcuity Inc
0.47%
98.4%82,800$7.15M
38
ALNY
Alnylam Pharmaceuticals Inc.
0.34%
98.8%25,040$5.15M
39
PSDTX
Putnam Short Term Investment Fund
0.32%
99.1%4,832,030$4.83M
40
CYTK
Cytokinetics Inc
0.28%
99.4%54,500$4.20M
41
NAMS
Newamsterdam Pharma Company Nv
0.22%
99.6%120,500$3.35M
42DebtUnited States Treasury Bill 12/10/2026
0.19%
99.8%2,900,000$2.86M
43DebtU.S. Treasury Bill 2026-10-22
0.14%
99.9%2,200,000$2.18M
44
ALLO
Allogene Therapeutics Inc
0.00%
99.9%--
45DebtTreasury Bill Jul 16, 2026
0.00%
99.9%--
46—Citibank Na Boston Scientific Corp Strike 100.0 Expires 2027-01-15 Call 01/15/2027
0.00%
99.9%169,544$20.7K
Not reported for this fund: share changes.
FundXLS Pro
See every sector, industry and share-change value
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

PHSRX Mutual Fund All Holdings

PHSRX holdings total 46 positions. The top 10 holdings account for 61.5% of the fund, led by Eli Lilly & Co. at 13.2%, Johnson & Johnson - Common at 9.3%, Unitedhealth Group Incorporated at 7.3%.

PHSRX portfolio concentration is relatively high, with the top 10 representing 61.5% of total assets. The largest sector exposure is Health Care at 78.2%.

PHSRX sectors provide a detailed breakdown. PHSRX overlap shows how holdings compare to other funds in your portfolio.